NEWS & RESOURCES

New Approaches to Meet Patients’ Higher Expectations

Paul McLean, president and CEO of ClarVista Medical, and John Doane, MD, speak with Mark Kontos, MD, regarding the challenges ophthalmologists face with regard to meeting patients’ expectations. Dr. McLean explains how his company seeks to meet these higher expectations with the development of the Harmoni modular IOL platform. Dr. Doane discusses another procedure that […]

ClarVista Medical Named Top Ophthalmology Innovation of 2015 by The Ophthalmologist

Award recognizes HARMONI’s potential to revolutionize cataract surgery with improved visual outcomes and patient care Aliso Viejo, CA ‐ December 15, 2015 ‐ ClarVista Medical, Inc.(www.clarvistamedical.com), an ophthalmic device company developing the HARMONI® Modular IOL system, announced today that The Ophthalmologist, a leading publication in the field of ophthalmology, selected the HARMONI system as the […]

ClarVista HARMONI® Receives CE Mark for Europe

Aliso Viejo, CA – September 28, 2015 – ClarVista Medical, Inc.( www.clarvistamedical.com), a privately-held ophthalmic device company, announced today it received CE (Conformite Europeenne) Mark of the HARMONI Modular Intraocular Lens (IOL) System for the visual correction of aphakia in adult patients in whom a cataractous lens has been removed. The unique modular design is […]

ClarVista Medical Completes $14 Million Series B Financing to Advance Novel Modular Intraocular Lens for Cataract Lens Replacement

Financing Will Support Clinical Development of HARMONITM Modular IOL Capable of Optimizing Vision After Cataract Surgery Aliso Viejo, California, May 22, 2015 – ClarVista Medical, Inc. (“ClarVista”), a privately-held ophthalmic device company developing the HARMONITM system, a novel modular and easily exchangeable intraocular lens (IOL) for lens replacement after cataract surgery, announced today that it […]

ClarVista Medical completes enrollment of the HARMONI Modular IOL first-in-human clinical trial

ClarVista Medical completes enrollment of the HARMONI Modular IOL first-in-human clinical trial